News
開拓藥業(09939.HK)公布，其自主研發的新型靶向雄激素受體(AR)的蛋白降解嵌合體(PROTAC)化合物GT20029治療痤瘡的該項II期臨床試驗讀出頂線數據。數據顯示，該項II期臨床試驗成功達... 開拓藥業(09939.HK) -0.030 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback